Red Blood Cell and Serum Magnesium Levels Among Children and Adolescents With Sickle Cell Anemia
- 71 Downloads
Patients with sickle cell anemia (SCA) can acquire many biochemical abnormalities, including altered magnesium levels. However, the roles of magnesium in the pathogenesis and management of SCA need to be determined. The aim of this work was to evaluate magnesium levels among pediatric patients with SCA in Basra, Iraq. The study employed a case-control design and examined 87 patients with SCA (3–15 years old) who had attended the Basra Center for Hereditary Blood Diseases while in a steady state and 90 apparently healthy control subjects. Complete blood count, red blood cell (RBC), and serum magnesium, calcium, potassium, sodium, zinc, and copper levels were measured in all subjects. The results revealed significantly lower RBC and serum magnesium levels among the patients with SCA (3.62 ± 0.42 and 1.35 ± 0.19 mg/dL, respectively) than those among the control subjects (4.47 ± 0.55 and 1.87 ± 0.27 mg/dL, respectively). In addition, compared to the control subjects, the patients with SCA had significantly lower serum levels of potassium, sodium, and zinc; significantly higher serum levels of copper; and significantly higher Ca/Mg and Na/Mg ratios. Among the SCA patients, the RBC magnesium level was significantly negatively associated with the frequencies of vaso-occlusive crises (r = − 0.423, P < 0.001) and disease-related hospitalization (r = − 0.225, P < 0.05). To conclude, the RBC magnesium level, but not the serum magnesium level, is significantly associated with vaso-occlusive crises and hospitalization. Therefore, screening and management of low RBC magnesium levels in SCA patients are required.
KeywordsMagnesium Sickle cell anemia Children
We thank Dr. Maysaa B. Al-Rudainee, family physician, Basra Health Directorate, and Dr. Assad Yehia, Professor of Animal Breeding, College of Agriculture, for their extensive assistance in conducting the statistical analysis of the data. We also thank Mrs. Sumaya S. Ali, Biochemistry Department, College of Medicine, Basra University, for her help and kind cooperation.
OA, MK, and LM designed and planned the study. OA collected the data and the samples, and LM performed the lab investigations. All authors contributed to the writing of the manuscript and have read and approved the final manuscript.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
All procedures in studies involving human participants were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 3.Ballas SK, Lieff S, Benjamin LJ, Dampier CD, Heeney MM, Hoppe C, Johnson CS, Rogers ZR, Smith-Whitley K, Wang WC, Telen MJ, on Behalf of the Investigators at the Comprehensive Sickle Cell Centers (2010) Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol 85:6–13. https://doi.org/10.1002/ajh.21550 CrossRefPubMedPubMedCentralGoogle Scholar
- 4.Hillman RS, Ault KA, Rinder HM (2005) Hemoglobinopathies. In: Hillman RS, Ault KA, Rinder HM (eds) Hematology in clinical practice. 4th edn. McGraw-Hill, Philadelphia, pp 80–94Google Scholar
- 6.Oladipo OO, Temiye EO, Ezeaka VC, Obomanu P (2005) Serum magnesium, phosphate and calcium in Nigerian children with sickle cell disease. West Afr. J Med 24:120–123Google Scholar
- 14.Aleem A (2008) Renal abnormalities in patients with sickle cell disease. A single center report from Saudi Arabia. Saudi J Kidney Dis Transplant 19:194–199Google Scholar
- 16.Brousseau DC, Scott JP, Badaki-Makun O, Darbari DS, Chumpitazi CE, Airewele GE, Ellison AM, Smith-Whitley K, Mahajan P, Sarnaik SA, Casper TC, Cook LJ, Dean JM, Leonard J, Hulbert ML, Powell EC, Liem RI, Hickey R, Krishnamurti L, Hillery CA, Nimmer M, Panepinto JA, for the Pediatric Emergency Care Applied Research Network (PECARN) (2015) A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children. Blood 126:1651–1657. https://doi.org/10.1182/blood-2015-05-647107 CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Omoti CE (2005) Hematological values in sickle cell anemia in steady state and during vaso-occlusive crisis in Benin City. Nigeria Annals Afr Med 4:62–67Google Scholar
- 23.Lo SF (2016) Reference intervals for laboratory tests and procedures, chapter 727. In: Kliegman RM, Stanton BF, St Geme JW III, Schor NF (eds) Nelson textbook of pediatrics, 20th edn. Elsevier, Inc., Philadelphia PA, pp 3464–3473Google Scholar
- 25.Khan JAJ (2003) Vitamin D status and serum level of some elements in children with sickle cell disease in Jeddah, Saudi Arabia. Pak J Med Sci 19:295–299Google Scholar
- 31.Gupta V, Singh AK, Saha J, Nigam P, Patil KSB, Singh N (2012) Variation in serum electrolyte in sickle cell patients in Chhattisgarh population. Int J Cur Sci Res 2:239–243Google Scholar
- 32.Than NN, Soe HHK, Palaniappan SK, Abas ABL, De Franceschi L (2017) Magnesium for treating sickle cell disease (Review). Cochrane Database of Systematic Reviews Issue 4. Art. No.: CD011358. https://doi.org/10.1002/14651858.CD011358.Pub2
- 34.Agoreyo FO, Nwanze N (2010) Plasma sodium and potassium changes in sickle cell patients. Int J Genet Mol Biol 2:014–019Google Scholar
- 35.Bara M, Guiet-Bara A, Durlach J (1993) Regulation of sodium and potassium pathways by magnesium in cell membranes. Manges Res 6(2):167–177Google Scholar
- 36.Nwaoguikpe RN, Braide W (2012) The antisickling effects of some micronutrients and antioxidant vitamins in sickle cell disease management. J med. Med Sci 3:334–340Google Scholar
- 37.Prasad AS (2013) Biochemistry of Zinc. Springer Science & Business Media, New York, pp 136–144Google Scholar
- 38.Maret W. (2013) Zinc and human disease. In: Sigel A., Sigel H., Sigel R. (eds) Interrelations between essential metal ions and human diseases. Metal Ions in Life Sciences, vol 13. Springer, DordrechtGoogle Scholar
- 41.Bot YS, Benjamin A, Nyango DY, Ventmack DT, Eunice CB, Etukudu NS et al (2013) Analyses of cu and Zn in serum of sickle cell disease patients in Jos. Afr J med. Biochemistry 1:1–4Google Scholar
- 42.Pandey S, Ranjan R, Toteja GS, Rao S, Mishra RM, Pandey SW et al (2011) Micronutrients status along with hematological and biochemical parameters in sickle subtypes: preliminary report from India. Rev Hematol Mex 12:131–137Google Scholar
- 43.Nagalla S, Ballas SK (2016) Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database of Systematic Reviews Issue 1. https://doi.org/10.1002/14651858.CD003426.pub5,
- 47.Emokpae AM, Adejumo BIG (2015) Serum total calcium to magnesium ratio is higher in sickle cell disease patients with proteinuria than without proteinuria. J Adv In Biol Basic Res 1(3):83–85Google Scholar